Chungcheongbuk-do, South Korea

Soo-Ik Chang


Average Co-Inventor Count = 8.6

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Cheongju-shi, KR (1998)
  • Chungcheongbuk-do, KR (2002 - 2004)

Company Filing History:


Years Active: 1998-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Soo-Ik Chang

Introduction

Soo-Ik Chang is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of angiogenesis inhibitors and cancer treatment solutions. With a total of three patents to his name, Chang's work has the potential to impact various medical applications.

Latest Patents

One of Chang's latest patents is focused on the "Process of purifying angiogenesis inhibitors." This invention relates to the purification of angiogenesis inhibitor proteins, specifically recombinant kringle 1-3, also known as greenstatin. The process allows for the solubilization, refolding, and purification of these proteins into a pure and active form. The purified greenstatin has been shown to specifically suppress endothelial cell proliferation, angiogenesis, and the growth of various cancers, including lung cancer, skin cancer, and brain tumors. This process is applicable for the mass production of angiogenesis inhibitor proteins, which can be useful in treating conditions such as glaucoma and retinopathy.

Another significant patent by Chang is for "8-Acetylarteminolide and process for preparing same." This compound exhibits inhibitory activities against farnesyl-protein transferase (FPTase) and has potential applications in the prevention and treatment of various cancers and angiogenesis-related diseases.

Career Highlights

Soo-Ik Chang has worked with prominent organizations such as the Korea Research Institute of Bioscience and Biotechnology and Korea Greencross Corporation. His experience in these institutions has contributed to his expertise in biotechnology and innovation.

Collaborations

Chang has collaborated with notable colleagues, including Byoung-Mog Kwon and Seung-Ho Lee. These partnerships have likely enhanced his research and development efforts in the field.

Conclusion

Soo-Ik Chang's innovative work in the field of biotechnology, particularly in the development of angiogenesis inhibitors, showcases his commitment to advancing medical science. His patents reflect a dedication to finding solutions for critical health issues, and his collaborations further strengthen his contributions to the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…